Monitoring As required by GCP, a monitoring procedure will be performed in order to oversee the progress of the clinical trial and ensure that it is conducted, recorded and reported in accordance with the protocol, standard operating procedures (SOPs), GCP and the applicable regulatory requirements. Because the risk classification of the current study is estimated to be "moderate risk", 2-3 monitor visits are required per year.